- Round ID
- FR-00385
- Stage
- Series D
- Round name
- Series D
- Amount
- £25.2M
Dated funding evidence
Mission Therapeutics
Series D · £25.2M · 2024-03-01
Reported round£25.2MSeries D
- Disclosure date
- 2024-03-01
- Reported currency
- GBP
- Companies House
- 07630933
- Evidence sources
- 2
2024-03-01Series D£25.2M
Resolved investor records
Pfizer Venture InvestmentsLead investorSofinnova PartnersLead investorRoche Venture FundLead investorSR OneInvestorIP GroupInvestorRosetta CapitalInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Pfizer Venture Investments, Sofinnova Partners, Roche Venture Fund
- Other investors
- SR One, IP Group, Rosetta Capital
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.